Review on allosteric modulators of dopamine receptors so far
Abstract Background Contemporary research is predominantly directed towards allosteric modulators, a class of compounds designed to interact with specific sites distinct from the orthosteric site on G protein‐coupled receptors. These allosteric modulators play a pivotal role in influencing diverse p...
| Published in: | Health Science Reports |
|---|---|
| Main Author: | Fentaw Girmaw |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-03-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/hsr2.1984 |
Similar Items
Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics
by: Irene Fasciani, et al.
Published: (2020-11-01)
by: Irene Fasciani, et al.
Published: (2020-11-01)
Functional Characterization of the Dopaminergic Psychostimulant Sydnocarb as an Allosteric Modulator of the Human Dopamine Transporter
by: Shaili Aggarwal, et al.
Published: (2021-06-01)
by: Shaili Aggarwal, et al.
Published: (2021-06-01)
The Role of Lipids in Allosteric Modulation of Dopamine D<sub>2</sub> Receptor—In Silico Study
by: Justyna Żuk, et al.
Published: (2022-02-01)
by: Justyna Żuk, et al.
Published: (2022-02-01)
In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators
by: Jiayi Yuan, et al.
Published: (2022-01-01)
by: Jiayi Yuan, et al.
Published: (2022-01-01)
Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D<sub>1</sub> Receptor
by: Tim J. Fyfe, et al.
Published: (2021-06-01)
by: Tim J. Fyfe, et al.
Published: (2021-06-01)
Allosteric Modulators of Dopamine D<sub>2</sub> Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis
by: Agnieszka A. Kaczor, et al.
Published: (2022-12-01)
by: Agnieszka A. Kaczor, et al.
Published: (2022-12-01)
Allosteric modulation of serotonin and dopamine transporters: New insights from computations and experiments
by: Hoang Nguyen, et al.
Published: (2024-01-01)
by: Hoang Nguyen, et al.
Published: (2024-01-01)
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators
by: Dina Manetti, et al.
Published: (2023-01-01)
by: Dina Manetti, et al.
Published: (2023-01-01)
Allosteric modulation of G protein-coupled receptor signaling
by: Siyuan Shen, et al.
Published: (2023-02-01)
by: Siyuan Shen, et al.
Published: (2023-02-01)
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
by: Silvia Pasquini, et al.
Published: (2022-10-01)
by: Silvia Pasquini, et al.
Published: (2022-10-01)
Targeted NMDA Receptor Interventions for Autism: Developmentally Determined Expression of GluN2B and GluN2A-Containing Receptors and Balanced Allosteric Modulatory Approaches
by: Stephen I. Deutsch, et al.
Published: (2022-01-01)
by: Stephen I. Deutsch, et al.
Published: (2022-01-01)
Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator
by: Mengrong Li, et al.
Published: (2022-12-01)
by: Mengrong Li, et al.
Published: (2022-12-01)
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
by: Jakub Jakowiecki, et al.
Published: (2021-04-01)
by: Jakub Jakowiecki, et al.
Published: (2021-04-01)
Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D<sub>2</sub> Receptor
by: Richard Ågren, et al.
Published: (2021-12-01)
by: Richard Ågren, et al.
Published: (2021-12-01)
Allosteric modulation and direct activation of glycine receptors by a tricyclic sulfonamide
by: César O. Lara, et al.
Published: (2025-02-01)
by: César O. Lara, et al.
Published: (2025-02-01)
Determination of the Cannabinoid CB1 Receptor’s Positive Allosteric Modulator Binding Site through Mutagenesis Studies
by: Hayley M. Green, et al.
Published: (2024-01-01)
by: Hayley M. Green, et al.
Published: (2024-01-01)
Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain
by: Chunhao Zhu, et al.
Published: (2024-01-01)
by: Chunhao Zhu, et al.
Published: (2024-01-01)
Design, Synthesis, and Biological Assessment of Novel Vanillin-Isoxazole Derivatives as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptor
by: Santiago Stabile, et al.
Published: (2023-11-01)
by: Santiago Stabile, et al.
Published: (2023-11-01)
Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey
by: Leonardo Brunetti, et al.
Published: (2024-05-01)
by: Leonardo Brunetti, et al.
Published: (2024-05-01)
Methods for negating the impact of zinc contamination to allow characterization of positive allosteric modulators of glycine receptors
by: Casey I. Gallagher, et al.
Published: (2024-06-01)
by: Casey I. Gallagher, et al.
Published: (2024-06-01)
Mechanism of Action and Structure–Activity Relationships of Tetracyclic Small Molecules Acting as Universal Positive Allosteric Modulators of the Cholecystokinin Receptor
by: Daniela G. Dengler, et al.
Published: (2023-01-01)
by: Daniela G. Dengler, et al.
Published: (2023-01-01)
Prospects for the use of allosteric drugs in real-world clinical practice
by: I. R. Svechkareva, et al.
Published: (2023-12-01)
by: I. R. Svechkareva, et al.
Published: (2023-12-01)
Targeting cryptic allosteric sites of G protein-coupled receptors as a novel strategy for biased drug discovery
by: Xin Qiao, et al.
Published: (2025-02-01)
by: Xin Qiao, et al.
Published: (2025-02-01)
Further In Vitro and Ex Vivo Pharmacological and Kinetic Characterizations of CCF219B: A Positive Allosteric Modulator of the α<sub>1A</sub>-Adrenergic Receptor
by: Robert S. Papay, et al.
Published: (2025-03-01)
by: Robert S. Papay, et al.
Published: (2025-03-01)
Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway
by: Kanako Miyano, et al.
Published: (2021-10-01)
by: Kanako Miyano, et al.
Published: (2021-10-01)
An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups
by: Riley Perszyk, et al.
Published: (2018-05-01)
by: Riley Perszyk, et al.
Published: (2018-05-01)
Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor
by: John E. Donello, et al.
Published: (2025-01-01)
by: John E. Donello, et al.
Published: (2025-01-01)
Insights into the Allosteric Regulation of Human Hsp90 Revealed by NMR Spectroscopy
by: Tjaša Goričan, et al.
Published: (2024-12-01)
by: Tjaša Goričan, et al.
Published: (2024-12-01)
Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain
by: Eva M García-Cuesta, et al.
Published: (2024-09-01)
by: Eva M García-Cuesta, et al.
Published: (2024-09-01)
Overview of the structure and function of the dopamine transporter and its protein interactions
by: Binod Nepal, et al.
Published: (2023-03-01)
by: Binod Nepal, et al.
Published: (2023-03-01)
Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities
by: Yazan J. Meqbil, et al.
Published: (2021-11-01)
by: Yazan J. Meqbil, et al.
Published: (2021-11-01)
Dopamine receptors and organ fibrosis
by: ZhongLi Liao, et al.
Published: (2025-03-01)
by: ZhongLi Liao, et al.
Published: (2025-03-01)
Apigenin and Structurally Related Flavonoids Allosterically Potentiate the Function of Human α7-Nicotinic Acetylcholine Receptors Expressed in SH-EP1 Cells
by: Waheed Shabbir, et al.
Published: (2021-05-01)
by: Waheed Shabbir, et al.
Published: (2021-05-01)
Distinct potency of compounds targeting the T1R3 subunit in modulating the response of human sweet and umami taste receptors
by: Maiko Kawasaki, et al.
Published: (2025-07-01)
by: Maiko Kawasaki, et al.
Published: (2025-07-01)
Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor
by: Hirohiko Hikichi, et al.
Published: (2015-03-01)
by: Hirohiko Hikichi, et al.
Published: (2015-03-01)
1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2
by: Monica Chinellato, et al.
Published: (2023-10-01)
by: Monica Chinellato, et al.
Published: (2023-10-01)
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
by: Asher L. Brandt, et al.
Published: (2022-10-01)
by: Asher L. Brandt, et al.
Published: (2022-10-01)
Dynamic allosteric networks drive adenosine A1 receptor activation and G-protein coupling
by: Miguel A Maria-Solano, et al.
Published: (2023-09-01)
by: Miguel A Maria-Solano, et al.
Published: (2023-09-01)
In Silico Identification and Experimental Validation of (−)-Muqubilin A, a Marine Norterpene Peroxide, as PPARα/γ-RXRα Agonist and RARα Positive Allosteric Modulator
by: Enrico D’Aniello, et al.
Published: (2019-02-01)
by: Enrico D’Aniello, et al.
Published: (2019-02-01)
The α-7 Nicotinic Receptor Positive Allosteric Modulator Alleviates Lipopolysaccharide Induced Depressive-like Behavior by Regulating Microglial Function, Trophic Factor, and Chloride Transporters in Mice
by: Sami Alzarea, et al.
Published: (2024-03-01)
by: Sami Alzarea, et al.
Published: (2024-03-01)
Similar Items
-
Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics
by: Irene Fasciani, et al.
Published: (2020-11-01) -
Functional Characterization of the Dopaminergic Psychostimulant Sydnocarb as an Allosteric Modulator of the Human Dopamine Transporter
by: Shaili Aggarwal, et al.
Published: (2021-06-01) -
The Role of Lipids in Allosteric Modulation of Dopamine D<sub>2</sub> Receptor—In Silico Study
by: Justyna Żuk, et al.
Published: (2022-02-01) -
In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators
by: Jiayi Yuan, et al.
Published: (2022-01-01) -
Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D<sub>1</sub> Receptor
by: Tim J. Fyfe, et al.
Published: (2021-06-01)
